Prime Medicine (PRME) Tax Provisions (2021 - 2024)
Prime Medicine (PRME) posted Tax Provisions of -$134000.0 for Q2 2024, down 200.0% on a QoQ basis from $134000.0 in Q1 2024, and down 532.26% year-over-year from $31000.0 in Q3 2023.
Prime Medicine (PRME) Tax Provisions (2021 - 2024) Analysis & Trends
Prime Medicine's Tax Provisions history runs 4 years deep, the most recent figure standing at -$134000.0 for Q2 2024.
- Quarterly Tax Provisions fell 532.26% year-over-year to -$134000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$134000.0 (down 335.09% YoY) and the FY2023 annual result came in at -$279000.0, up 70.57% from the prior year.
- Tax Provisions was -$134000.0 for Q2 2024 at Prime Medicine, down from $134000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.4 million in Q4 2021 and bottomed at -$2.4 million in Q3 2021.
- A 4-year average of -$201454.5 and a median of -$134000.0 in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 166.34% in 2024, while the deepest fall reached 532.26% in 2024.
- Prime Medicine's Tax Provisions stood at $1.4 million in 2021, then slumped by 113.47% to -$186000.0 in 2022, then soared by 41.94% to -$108000.0 in 2023, then dropped by 24.07% to -$134000.0 in 2024.
- Business Quant data shows PRME's Tax Provisions at -$134000.0 in Q2 2024, $134000.0 in Q1 2024, and -$108000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -134,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Sep 30, 2023 | -108,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | -202,000.00 |
| Dec 31, 2022 | -186,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -532,000.00 |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | -2.37 Mn |